Forge Nano

Forge Nano

Develops nanocoatings to enhance manufacturing performance

Overview

Forge Nano develops and deploys Atomic Armor, a nanocoating that enhances manufactured products, especially in semiconductors and powders. Atomic Armor is deposited at the nanoscale onto surfaces or powders, improving battery life, fuel stability, medicine shelf life, and wafer durability. The company differentiates itself with a scalable, industry-grade coating platform proven across diverse materials, building on its lab-to-commercial scaling heritage from the University of Colorado ALD group. Its goal is to help manufacturers boost performance and sustainability by applying durable nanoscale coatings at scale.

About Forge Nano

Simplify's Rating
Why Forge Nano is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Energy

Company Size

51-200

Company Stage

Series D

Total Funding

$450.8M

Headquarters

Thornton, Colorado

Founded

2011

Get referred to Forge Nano

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 22, 2026 registration became effective, clearing a major hurdle for the NASDAQ listing.
  • Samsung SDI invested $20 million and committed conditional cell purchases starting in 2028.
  • DOE-backed Morrisville expansion targets 3 GWh annually and more than 250 North Carolina jobs.

What critics are saying

  • ATII merger still needs October 16, 2026 shareholder approval; failure blocks public listing.
  • Morrisville gigafactory starts in 2028, leaving execution risk before any scaled battery revenue.
  • Forge Nano’s $40 million 2026 revenue target is small against a $300 million buildout.

What makes Forge Nano unique

  • Atomic Armor spans semiconductors, batteries, and pharma, extending Forge Nano beyond one market.
  • Samsung SDI partnership gives Forge Nano manufacturing know-how and a 2028 procurement path.
  • Nanexa JDA on September 22, 2026 validates ALD coatings in GMP pharmaceutical equipment.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$450.8M

Above

Industry Average

Funded Over

10 Rounds

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.
Series D Funding Comparison
Above Average

Industry standards

$77M
$70M
Twilio
$80M
Handshake
$97M
Forge Nano
$100M
Affirm

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

Paid Holidays

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Ohsem.me
Sep 22nd, 2026
Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines.

Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines. 22/09/2026 * Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa's broad portfolio of proprietary and partnered PharmaShell(R) programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell(R) drug delivery platform and its portfolio of proprietary and partnered programs. Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale production across the Nanexa's PharmaShell(R) portfolio. The infrastructure and process know-how potentially gained through the collaboration will find its use in multiple PharmaShell(R)-enabled therapeutic programs. Nanexa's PharmaShell(R) technology is designed to enable long-acting formulations through precisely engineered nanoscale coatings using the ALD technology. The platform can be applied to a broad range of active pharmaceutical ingredients, including small molecules and biologics, across multiple therapeutic areas. The collaboration combines Nanexa's expertise in drug delivery and pharmaceutical development with Forge Nano's capabilities in industrial ALD process development and equipment engineering. The broad potential of the platform is further illustrated by NEX-22, Nanexa's proprietary GLP-1 programme, where preclinical and clinical proof of concept have demonstrated the feasibility of achieving a once-monthly depot formulation. "This agreement demonstrates the potential to apply Forge Nano's ALD expertise to pharmaceutical manufacturing, where process control, repeatability, and scalability are critical," said Paul Lichty, Chief Executive Officer of Forge Nano. "Through this collaboration, we intend to establish flexible manufacturing capabilities that can support a wide range of PharmaShell(R)-enabled products as they progress towards clinical and commercial scale." The agreement builds on the companies' existing relationship and is intended to create a pathway towards increased manufacturing capacity as Nanexa's proprietary and partnered PharmaShell(R) programs progress through development. These include Nanexa's internal product portfolio, its license agreement with Moderna and other undisclosed collaborations with pharmaceutical companies. Any future commercialization of PharmaShell(R)-enabled products remain subject to successful development, regulatory approvals and other factors. "This collaboration is an important milestone, and the timing of the partnership is well aligned with our project portfolio and provides a clear path towards increased manufacturing capacity as our projects advance" said David Westberg, CEO of Nanexa. "As our programs progress and interest from pharmaceutical partners continues to increase, access to scalable manufacturing solutions becomes increasingly important. Forge Nano brings substantial expertise in industrial ALD technology and will help position Nanexa for future commercial manufacturing needs," said Mårten Rooth, CTO of Nanexa. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. ABOUT NANEXA Nanexa is bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation. The company's proprietary PharmaShell(R) platform is a unique drug delivery system that enables a high drug load, thus low injection volume, creating a new generation of 'super generic' formulations that will provide greater convenience and reduce costs in the treatment of conditions such as metabolic diseases like type 2 diabetes and obesity, hematology/oncology, cardiovascular disorders, psychiatry, and many others. Nanexa develops its own products and also has collaboration agreements with several pharma companies, including the latest license and option agreement with Moderna. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected] 02/07/2026 18/08/2014 13/05/2026 27/04/2026 30/04/2026 Discover more Deploy Enterprise Cloud Latest gadgets

GlobeNewswire
Sep 22nd, 2026
Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines.

Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines. September 22, 2026 08:47 ET | Source: Forge Nano * Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa's broad portfolio of proprietary and partnered PharmaShell(R) programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell(R) drug delivery platform and its portfolio of proprietary and partnered programs. Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale production across the Nanexa's PharmaShell(R) portfolio. The infrastructure and process know-how potentially gained through the collaboration will find its use in multiple PharmaShell(R)-enabled therapeutic programs. Nanexa's PharmaShell(R) technology is designed to enable long-acting formulations through precisely engineered nanoscale coatings using the ALD technology. The platform can be applied to a broad range of active pharmaceutical ingredients, including small molecules and biologics, across multiple therapeutic areas. The collaboration combines Nanexa's expertise in drug delivery and pharmaceutical development with Forge Nano's capabilities in industrial ALD process development and equipment engineering. The broad potential of the platform is further illustrated by NEX-22, Nanexa's proprietary GLP-1 programme, where preclinical and clinical proof of concept have demonstrated the feasibility of achieving a once-monthly depot formulation. "This agreement demonstrates the potential to apply Forge Nano's ALD expertise to pharmaceutical manufacturing, where process control, repeatability, and scalability are critical," said Paul Lichty, Chief Executive Officer of Forge Nano. "Through this collaboration, we intend to establish flexible manufacturing capabilities that can support a wide range of PharmaShell(R)-enabled products as they progress towards clinical and commercial scale." The agreement builds on the companies' existing relationship and is intended to create a pathway towards increased manufacturing capacity as Nanexa's proprietary and partnered PharmaShell(R) programs progress through development. These include Nanexa's internal product portfolio, its license agreement with Moderna and other undisclosed collaborations with pharmaceutical companies. Any future commercialization of PharmaShell(R)-enabled products remain subject to successful development, regulatory approvals and other factors. "This collaboration is an important milestone, and the timing of the partnership is well aligned with our project portfolio and provides a clear path towards increased manufacturing capacity as our projects advance" said David Westberg, CEO of Nanexa. "As our programs progress and interest from pharmaceutical partners continues to increase, access to scalable manufacturing solutions becomes increasingly important. Forge Nano brings substantial expertise in industrial ALD technology and will help position Nanexa for future commercial manufacturing needs," said Mårten Rooth, CTO of Nanexa. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. ABOUT NANEXA Nanexa is bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation. The company's proprietary PharmaShell(R) platform is a unique drug delivery system that enables a high drug load, thus low injection volume, creating a new generation of 'super generic' formulations that will provide greater convenience and reduce costs in the treatment of conditions such as metabolic diseases like type 2 diabetes and obesity, hematology/oncology, cardiovascular disorders, psychiatry, and many others. Nanexa develops its own products and also has collaboration agreements with several pharma companies, including the latest license and option agreement with Moderna. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected]

Associated Press
Sep 17th, 2026
Forge Nano expands AI partnership with Voltaiq for battery development at new 3 GWh gigafactory

Forge Nano has expanded its partnership with Voltaiq to integrate artificial intelligence across its battery operations. The collaboration will embed Voltaiq's Battery Intelligence platform throughout Forge Nano's US battery development and production facilities. As Forge Nano scales towards high-volume manufacturing, it will use AI to accelerate development, improve quality and provide faster insights. The company recently broke ground on a 3 GWh/year gigafactory in Morrisville, North Carolina, targeting high-performance defence and aerospace applications. Voltaiq's enterprise software will support the entire product lifecycle, enabling engineers to rapidly identify manufacturing anomalies, quality issues and equipment problems during production. The platform unifies electrochemical, materials and process data, giving engineers visibility into performance differences. Forge Nano is merging with Archimedes Tech SPAC Partners II Co.

TMCnet
Aug 19th, 2026
Forge Nano Breaks Ground on "America's Battery Gigafactory" to Strengthen U.S. Defense Supply Chains

Forge Nano Breaks Ground on "America's Battery Gigafactory" to Strengthen U.S. Defense Supply Chains TMCnet News [August 19, 2026] | / | Forge Nano Breaks Ground on "America's Battery Gigafactory" to Strengthen U.S. Defense Supply Chains * DOE-backed facility will expand to nearly 315,000 square feet, create more than 250 jobs and scale domestic battery manufacturing capacity to up to 3 GWh annually * Samsung SDI partnership brings strategic investment, manufacturing expertise and commercial support to Forge Nano's U.S. battery manufacturing platform * Senator Ted Budd, Representative Deborah Ross, Morrisville Mayor TJ Cawley and Assistant Secretary of the Department of Energy Audrey Robertson joined Forge Nano to mark the company's next phase of U.S. manufacturing growth DENVER and MORRISVILLE, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today celebrated the groundbreaking of a major expansion of its lithium-ion battery manufacturing facility in Morrisville, North Carolina. Forge Nano executive leadership team breaks ground on its Morrisville, NC lithium-ion battery manufacturing facility alongside North Carolina Senator Ted Budd, U.S. Representative Deborah Ross, Mayor of Morrisville TJ Cawley and the Assistant Secretary of the Department of Energy Audrey Robertson. U.S. Senator Ted Budd, U.S. Representative Deborah Ross, Morrisville Mayor TJ Cawley and Assistant Secretary of the Department of Energy Audrey Robertson joined Forge Nano CEO Paul Lichty, employees, strategic partners and community leaders at the facility to mark the milestone and highlight the importance of expanding domestic battery manufacturing capacity for defense, aerospace and other critical U.S. markets. The expansion will transform Forge Nano's existing 100,000-square-foot Morrisville operation into a manufacturing campus approaching 315,000 square feet, create more than 250 jobs in North Carolina and establish approximately 3 gigawatt-hours ("GWh") of annual battery cell manufacturing capacity at full production. The facility is designed to address one of the most significant vulnerabilities facing the U.S. battery industry: the nation's dependence on foreign-controlled supply chains for batteries used in applications critical to national security. Forge Nano's Gigafactory is intended to establish a secure, U.S.-based manufacturing hub capable of supplying advanced lithium-ion batteries at scale. "Today's groundbreaking marks an important step toward building a battery supply chain in America," said Paul Lichty, CEO of Forge Nano. "We're combining Forge Nano's technology with world-class manufacturing expertise, federal suport and North Carolina's growing advanced manufacturing ecosystem to bring critical battery production to the United States. America's Battery Gigafactory will give defense, aerospace and commercial customers access to advanced battery cells manufactured here at home, at the scale needed to compete globally." The project is financed by up to $100 million in non-dilutive funding from the U.S. Department of Energy and reflects a collaborative effort among Forge Nano, federal and state partners and strategic industry collaborators to strengthen America's domestic battery supply chain. "Maintaining America's technological edge requires strategic investment in our national security and commercial interests. Forge Nano's new Morrisville facility will strengthen U.S. battery manufacturing capabilities - advancing American leadership in critical technologies, expanding domestic production, and helping us compete with China. North Carolina's strong workforce and business climate make it an ideal place to grow this cutting-edge industry. This partnership will strengthen our domestic manufacturing base, create new opportunities for American workers, and keep North Carolina at the forefront of innovation," said Senator Budd. "North Carolina's Research Triangle has long been a center for innovation, and investments like Forge Nano's are helping translate that progress into advanced manufacturing and good-paying jobs here at home," said Congresswoman Deborah Ross. "Expanding domestic battery production will drive economic growth, create jobs, support our clean energy transition, and strengthen America's technology supply chain. I was proud to play a small role in bringing this expansion to life by passing the Bipartisan Infrastructure Law. I look forward to seeing how Morrisville and the Triangle continue leading the next generation of American manufacturing." "These batteries will not only serve commercial markets, but also the defense and aerospace applications on which our military depends," said Assistant Secretary of Energy Audrey Robertson. "That is exactly the kind of manufacturing capacity our country needs. We need to build critical technologies in America. We need to support our armed forces with secure supply chains. And American companies should be able to compete and win in the industries that will define the decades ahead." Building Domestic Battery Capacity at Scale Expansion construction is expected to begin imminently, with manufacturing equipment scheduled to be delivered over the next 2 years. Production at the facility is expected to begin in 2028. At full production, 3 GWh represents approximately 150 million battery cells per year. Depending on customer demand and product mix, that capacity could support approximately 10-20 million drone batteries, 34,000 electric military vehicles, 6 million BB-2590 radio batteries, 900 6T (Type 2) batteries, or approximately 275 energy storage system containers annually. The timing of the expansion is expected to align with new National Defense Authorization Act ("NDAA") battery sourcing requirements taking effect in 2028, further increasing the need for secure domestic sources of advanced battery cells for defense applications. Samsung SDI Partnership Supports U.S. Reshoring A central component of Forge Nano's U.S. battery manufacturing strategy is its strategic partnership with Samsung SDI, one of the world's leading battery manufacturers. Samsung SDI is supporting Forge Nano in establishing and beginning operations at the Morrisville facility, providing operational and manufacturing expertise for high-throughput battery production. Once the Gigafactory is operational, Forge Nano expects to manufacture Samsung SDI battery cells alongside Forge Nano's existing cell products in North Carolina. Samsung SDI has also entered into a conditional procurement agreement to purchase cells manufactured at the Gigafactory beginning in 2028, while Forge Nano is a contract manufacturer and an authorized distributor of Samsung SDI battery cells in the U.S. market. The companies are also working to advance the incorporation of Forge Nano's proprietary Atomic Armor(R) technology into future Samsung SDI battery products. Samsung SDI further strengthened the partnership in July through a $20 million strategic investment in Forge Nano, including $10 million in Forge Nano's Series D financing and $10 million in the company's PIPE financing associated with its planned public listing. Investing in North Carolina's Advanced Manufacturing Workforce Forge Nano selected North Carolina for the expansion based on the state's growing advanced manufacturing ecosystem, its pipeline of skilled workers from universities, community colleges and technical programs, competitive state and local incentives and its strong support for companies investing in advanced U.S. manufacturing. The Morrisville location also positions Forge Nano within the Research Triangle's deep technical and engineering talent base and provides a strong logistical position for transporting battery cells to defense, aerospace, industrial and other customers. As the Gigafactory ramps toward full production, Forge Nano expects the facility to create more than 250 jobs across advanced manufacturing, engineering, operations and technical roles. The project represents a significant investment in both domestic battery manufacturing capacity and the workforce needed to sustain that capacity over the long term. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. Contacts: Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected] Investor Relations Contact Bryan Baritot Alliance Advisors IR [email protected] A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42a740fd-7057-45f8-a33e-e3320da62ea0 [ Back To TMCnet.com's Homepage] |

GlobeNewswire
Jul 14th, 2026
Forge Nano secures $23M PIPE financing at $10 per share, closes $97M Series D with Samsung ahead of NASDAQ listing

Forge Nano has secured an additional $23 million in PIPE financing, bringing total commitments to $123 million ahead of its planned NASDAQ listing. The semiconductor equipment and advanced materials company priced all new shares at $10.00. Samsung SDI made a $20 million strategic investment, split between $10 million in the PIPE financing and $10 million in Forge Nano's Series D round. Horizons Ventures also participated in the PIPE financing. Forge Nano has closed its Series D at $97 million, completing its pre-IPO capital formation. Assuming no redemptions, the company expects over $367 million in pro forma cash following its merger with Archimedes Tech SPAC Partners II, combining $244 million in trust with the $123 million PIPE. The transaction is expected to close in the second half of 2026.

Recently Posted Jobs

Sign up to get curated job recommendations

Forge Nano is Hiring for 18 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →